Patent · US Active

IL-17A antibodies

US8519107B2 · kind B2 · utility

10Cited by
4References
16Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 29, 2010
Grant dateAug 27, 2013
Priority date
Expiry dateOct 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Interleukin-17A (IL-17A) antibody antagonists, polynucleotides encoding IL-17A antibody antagonists or fragments thereof, and methods of making and using the foregoing are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.